Viewing Study NCT02161120


Ignite Creation Date: 2025-12-25 @ 4:26 AM
Ignite Modification Date: 2026-03-02 @ 6:32 AM
Study NCT ID: NCT02161120
Status: COMPLETED
Last Update Posted: 2015-03-31
First Post: 2014-06-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Effect of Two Different Rye Bread Types in Irritable Bowel Syndrome
Sponsor: Oy Karl Fazer Ab
Organization:

Study Overview

Official Title: Effects of Traditional and Low-FODMAP Rye Bread in Irritable Bowel Syndrome.
Status: COMPLETED
Status Verified Date: 2015-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this study is to evaluate if low-FODMAP (Fermented Oligo-, Di-, Monosaccharides And Polyols) rye bread is better tolerated in irritable bowel syndrome than commonly available traditional rye bread higher in FODMAP carbohydrates. The study also aims to investigate patients' compliance to rye bread regimen, potential changes is gut microbiota and hydrogen production during the test periods (a marker of large bowel fermentation of poorly absorbed carbohydrates).
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: